| RS387907044 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS387907045 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS387907046 |
DNAJB6
|
Health Risk |
Pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS387907047 |
DNAJB6
|
Health Risk |
Pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS387907048 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS387907049 |
HEPACAM
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2A |
| RS387907050 |
HEPACAM
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2A |
| RS387907051 |
HEPACAM
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2A |
| RS387907052 |
HEPACAM
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2A |
| RS387907053 |
HEPACAM
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting |
| RS387907054 |
HEPACAM
|
Health Risk |
Likely pathogenic |
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING |
| RS387907055 |
HEPACAM
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting |
| RS387907056 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 3A |
| RS387907057 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS387907058 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 9/15, digenic |
| RS387907059 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis 12, Nephronophthisis 12 |
| RS387907060 |
TTC21B
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 4, Asphyxiating thoracic dystrophy 4 |
| RS387907061 |
AARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS387907062 |
ZNF469
|
Health Risk |
Pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS387907063 |
ZNF469
|
Health Risk |
Pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS387907064 |
ADAMTSL2
|
Health Risk |
Likely pathogenic |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS387907065 |
ADAMTSL2
|
Health Risk |
Pathogenic |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS387907066 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS387907067 |
SLC29A3
|
Health Risk |
Pathogenic/Likely pathogenic |
H syndrome, SLC29A3-related disorder |
| RS387907068 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS387907069 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS387907070 |
TMEM70
|
Health Risk |
Pathogenic |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS387907071 |
MEGF10
|
Health Risk |
Pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS387907072 |
MEGF10
|
Health Risk |
Pathogenic/Likely pathogenic |
MEGF10-related myopathy, Congenital myopathy 10b |
| RS387907073 |
MEGF10
|
Health Risk |
Pathogenic |
Congenital myopathy 10b, mild variant |
| RS387907075 |
COLEC11
|
Health Risk |
Pathogenic |
3MC syndrome 2, 3MC syndrome 2 |
| RS387907076 |
COLEC11
|
Health Risk |
Pathogenic |
3MC syndrome 2, Malignant tumor of urinary bladder |
| RS387907077 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS387907078 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS387907079 |
NEXN
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 20, Hypertrophic cardiomyopathy 20 |
| RS387907080 |
CTC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebroretinal microangiopathy with calcifications and cysts 1, Dyskeratosis congenita |
| RS387907081 |
CANT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS387907082 |
WDR62
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 2, primary |
| RS387907083 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS387907084 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS387907085 |
WDR35
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS387907086 |
SCARF2
|
Health Risk |
Likely pathogenic |
Van den Ende-Gupta syndrome, Van den Ende-Gupta syndrome |
| RS387907087 |
FOXRED1
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 19 |
| RS387907088 |
MSRB3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 74, Hearing loss |
| RS387907089 |
ANO10
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS387907090 |
KBTBD13
|
Health Risk |
Pathogenic |
Nemaline myopathy 6, Nemaline myopathy 6 |
| RS387907092 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia |
| RS387907093 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia |
| RS387907094 |
TTC19
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS387907095 |
PRSS56
|
Health Risk |
Pathogenic |
Isolated microphthalmia 6, Isolated microphthalmia 6 |
| RS387907096 |
PRSS56
|
Health Risk |
Pathogenic |
Isolated microphthalmia 6, Isolated microphthalmia 6 |
| RS387907097 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 35, Acute myeloid leukemia |
| RS387907098 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 35, Spinocerebellar ataxia type 35 |
| RS387907099 |
COA5
|
Health Risk |
Pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS387907101 |
BPNT2
|
Health Risk |
Pathogenic |
Chondrodysplasia with joint dislocations, gPAPP type |
| RS387907102 |
BPNT2
|
Health Risk |
Pathogenic |
Chondrodysplasia with joint dislocations, gPAPP type |
| RS387907103 |
BPNT2
|
Health Risk |
Pathogenic |
Chondrodysplasia with joint dislocations, gPAPP type |
| RS387907104 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS387907105 |
ZBTB24
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS387907106 |
ZBTB24
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS387907107 |
IFT43
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 3, Cranioectodermal dysplasia 3 |
| RS387907108 |
SPECC1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculomaxillofacial dysostosis, Oculomaxillofacial dysostosis |
| RS387907109 |
ZNF644
|
Health Risk |
Pathogenic |
Myopia 21, autosomal dominant |
| RS387907110 |
PRDM5
|
Health Risk |
Pathogenic |
Brittle cornea syndrome 2, Brittle cornea syndrome 2 |
| RS387907111 |
PRDM5
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 2, Brittle cornea syndrome 2 |
| RS387907112 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS387907113 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS387907114 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS387907115 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS387907117 |
HSD11B2
|
Health Risk |
Pathogenic |
Apparent mineralocorticoid excess, Apparent mineralocorticoid excess |
| RS387907118 |
ACSF3
|
Health Risk |
Pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS387907119 |
ACSF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS387907121 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS387907123 |
BICC1
|
Health Risk |
risk factor |
Renal dysplasia, cystic |
| RS387907125 |
PRRT2
|
Health Risk |
Pathogenic |
Infantile convulsions and choreoathetosis, Episodic kinesigenic dyskinesia |
| RS387907126 |
PRRT2
|
Health Risk |
Pathogenic |
Infantile convulsions and choreoathetosis, Episodic kinesigenic dyskinesia |
| RS387907127 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia 1, Infantile convulsions and choreoathetosis |
| RS387907128 |
PRRT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic kinesigenic dyskinesia 1, Episodic kinesigenic dyskinesia |
| RS387907129 |
RHBDF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Palmoplantar keratoderma-esophageal carcinoma syndrome |
| RS387907130 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Palmoplantar keratoderma-esophageal carcinoma syndrome |
| RS387907131 |
TMEM237
|
Health Risk |
Pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS387907132 |
TMEM138
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS387907133 |
TMEM138
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS387907134 |
TMEM138
|
Health Risk |
Pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS387907135 |
TMEM138
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 16, Joubert syndrome and related disorders |
| RS387907136 |
CFAP418
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 16, Bardet-biedl syndrome 21 |
| RS387907137 |
CFAP418
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 64 |
| RS387907138 |
GPR179
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS387907139 |
NDUFA12
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 23 |
| RS387907140 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS387907141 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, ARID1B-related BAFopathy |
| RS387907142 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS387907143 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS387907144 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Inborn genetic diseases |
| RS387907145 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS387907146 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS387907147 |
SKIC3
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS387907148 |
SKIC3
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS387907149 |
CEACAM16
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 4B, Autosomal dominant nonsyndromic hearing loss 4B |
| RS387907150 |
DNAJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Ehlers-Danlos syndrome |